LVCE Stock Overview
LiveCare, Inc. focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.
LiveCare, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$1.50|
|52 Week High||US$3.15|
|52 Week Low||US$1.00|
|1 Month Change||-9.09%|
|3 Month Change||-13.79%|
|1 Year Change||-33.33%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-25.00%|
Recent News & Updates
|LVCE||US Pharmaceuticals||US Market|
Return vs Industry: LVCE underperformed the US Pharmaceuticals industry which returned 8.7% over the past year.
Return vs Market: LVCE underperformed the US Market which returned -21.5% over the past year.
|LVCE Average Weekly Movement||n/a|
|Pharmaceuticals Industry Average Movement||11.0%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: Insufficient data to determine LVCE's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine LVCE's volatility change over the past year.
About the Company
LiveCare, Inc. focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach. The company is a real-time health, analytics, service, and monitoring company that provides persons with type II diabetes with solutions. The company was incorporated in 2018 and is based in Venice, Florida.
LiveCare, Inc. Fundamentals Summary
|LVCE fundamental statistics|
Is LVCE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LVCE income statement (TTM)|
|Cost of Revenue||US$6.82m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.19|
|Net Profit Margin||-648.23%|
How did LVCE perform over the long term?See historical performance and comparison